Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/25/2026 | Q4 | $293.2M | -- | -- | $0.14 | -- |
| 11/05/2025 | Q3 | $277.2M | $278.6M | $0.42 | $0.15 | $0.28 |
| 08/06/2025 | Q2 | $262.2M | $264.6M | $0.16 | $0.14 | $0.02 |
| 05/08/2025 | Q1 | $239M | $244.3M | $0.11 | $0.11 | $0.01 |
| 02/26/2025 | Q4 | $272.1M | $259.6M | $0.86 | $0.22 | $0.64 |
| 11/06/2024 | Q3 | $248.8M | $250.4M | $0.20 | $0.14 | $0.06 |
| 08/06/2024 | Q2 | $235.7M | $242M | $0.20 | $0.18 | $0.02 |
| 05/08/2024 | Q1 | $208.6M | $205.8M | $0.10 | $0.06 | $0.04 |
| 02/27/2024 | Q4 | $223.8M | $231M | $0.28 | $0.31 | -$0.03 |
| 11/02/2023 | Q3 | -- | -- | -$0.40 | -$0.42 | $0.02 |
| 08/02/2023 | Q2 | -- | -- | $0.01 | -$0.12 | $0.13 |
| 05/08/2023 | Q1 | -- | -- | -$0.27 | -$0.21 | -$0.06 |
| 02/27/2023 | Q4 | -- | -- | -$0.26 | -$0.25 | -$0.01 |
| 11/02/2022 | Q3 | -- | -- | -$0.17 | -$0.20 | $0.03 |
| 08/08/2022 | Q2 | -- | -- | -$0.21 | -$0.25 | $0.04 |
| 05/04/2022 | Q1 | -- | -- | -$0.70 | -$0.60 | -$0.10 |
| 02/28/2022 | Q4 | -- | -- | -$0.27 | -$0.24 | -$0.03 |
| 11/08/2021 | Q3 | -- | -- | -$0.09 | -$0.26 | $0.17 |
| 08/04/2021 | Q2 | -- | -- | -$0.27 | -$0.30 | $0.03 |
| 05/05/2021 | Q1 | -- | -- | -$0.42 | -- | -- |
| 02/24/2021 | Q4 | -- | -- | -$0.42 | -- | -- |
| 11/04/2020 | Q3 | -- | -- | -$0.54 | -- | -- |
| 08/05/2020 | Q2 | -- | -- | -$0.27 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$0.57 | -- | -- |
| 02/26/2020 | Q4 | -- | -- | -$0.34 | -- | -- |
| 10/30/2019 | Q3 | -- | -- | -$0.29 | -- | -- |
| 07/31/2019 | Q2 | -- | -- | -$0.38 | -- | -- |
| 05/01/2019 | Q1 | -- | -- | -$0.59 | -- | -- |
| 02/26/2019 | Q4 | -- | -- | -$0.50 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | -$0.50 | -- | -- |
| 08/08/2018 | Q2 | -- | -- | -$0.51 | -- | -- |
| 05/04/2018 | Q1 | -- | -- | -$0.44 | -- | -- |
| 02/27/2018 | Q4 | -- | -- | -$0.55 | -- | -- |
| 11/07/2017 | Q3 | -- | -- | -$0.53 | -- | -- |
| 08/08/2017 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/09/2017 | Q1 | -- | -- | -$0.72 | -- | -- |
| 02/28/2017 | Q4 | -- | -- | -$0.65 | -- | -- |
| 11/07/2016 | Q3 | -- | -- | -$0.61 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.63 | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -$0.45 | -- | -- |
| 02/29/2016 | Q4 | -- | -- | -$0.45 | -- | -- |
ACADIA Pharmaceuticals, Inc. reported $278.6M worth of top line sales in its most recent quarter.
ACADIA Pharmaceuticals, Inc. announced earnings per share of $0.42 which represents a beat of analyst forecast a $0.15 per share.
ACADIA Pharmaceuticals, Inc. reported $257M that represents $1.51 per share over the last quarter.
ACADIA Pharmaceuticals, Inc.'s earnings are forecast to decrease from $1.36 per share to $0.74 per share next year representing a decrease of -40.15%.
ACADIA Pharmaceuticals, Inc.'s next earnings date is February 25, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.